Clinical Trial

Manual Therapy on Oral Opening, Swallow Function and Upper Quarter Mobility on Head and Neck Cancer Survivors

Study acronym: MaTeO
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 30, 2025 (before its estimated October 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Trismus has been reported as the second most common comorbidity in survivors of head and neck cancer (HNC). It is mainly associated with post-radiotherapy subcutaneous fibrosis, muscular atrophy, damage to neurological structures in the neck, or a combination of all, affecting masticatory musculature. In addition to this, the loss of flexibility and strength in the shoulder has also been shown to be related to deficits in the function and quality of life of these patients. The goal of this clinical trial is to determinate the effectiveness and safety of Manual Therapy (MT) on Oral Opening, Swallow Function, as well as the mobility of the upper quarter, the strength of cervical musculature, pain, functionality, and the perception of quality of life in head and neck cancer survivors. Participants will be assigned randomly to the study groups: a) manual therapy program and control motor exercises and b) motor control exercises (usual care). The assessment refers to a baseline form (at the beginning of the study), at 6 weeks and at 6 weeks of patient follow-up.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-11-17; most recent amendment 2025-05-23.
Status change: Not Yet Recruiting → Recruiting 2024-10-17
Trial Details
NCT Number NCT06148077
Lead Sponsor Universidad de La Frontera
Conditions Head and Neck Cancer, Trismus, Dysfunction
Enrollment 70 participants
Start Date 2024-09-25
Primary Completion 2025-10-01 (estimated)
Study Completion 2025-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-30